Atai Life Sciences Total Long-Term Assets 2020-2024 | ATAI

Atai Life Sciences total long-term assets from 2020 to 2024. Total long-term assets can be defined as the sum of all assets classified as non-current
Atai Life Sciences Annual Total Long-Term Assets
(Millions of US $)
2023 $108
2022 $18
2021 $39
2020 $12
2019 $23
Atai Life Sciences Quarterly Total Long-Term Assets
(Millions of US $)
2024-09-30 $83
2024-06-30 $98
2024-03-31 $152
2023-12-31 $108
2023-09-30 $92
2023-06-30 $11
2023-03-31 $13
2022-12-31 $18
2022-09-30 $25
2022-06-30 $25
2022-03-31 $35
2021-12-31 $39
2021-09-30 $42
2021-06-30 $48
2021-03-31 $14
2020-12-31 $12
2020-09-30
2020-06-30
2020-03-31
2019-12-31 $23
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $0.305B $0.000B
atai Life Sciences B.V. is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. atai Life Sciences B.V. is based in BERLIN.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $21.804B 0.00
Quest Diagnostics (DGX) United States $19.317B 19.51
DaVita (DVA) United States $11.363B 14.49
Encompass Health (EHC) United States $9.962B 22.32
Chemed (CHE) United States $8.236B 25.31
Elanco Animal Health (ELAN) United States $5.492B 13.07
Option Care Health (OPCH) United States $5.459B 25.87
RadNet (RDNT) United States $4.453B 98.62
Amedisys (AMED) United States $2.998B 21.34
LifeStance Health (LFST) United States $2.904B 0.00
Addus HomeCare (ADUS) United States $1.974B 22.91
Astrana Health (ASTH) United States $1.946B 26.61
U.S Physical Therapy (USPH) United States $1.298B 34.13
Pennant (PNTG) United States $0.864B 34.93
Aveanna Healthcare Holdings (AVAH) United States $0.799B 0.00
Bioqual (BIOQ) United States $0.054B 0.00
Daxor (DXR) United States $0.036B 0.00
Ontrak (OTRK) United States $0.007B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.004B 0.00
IMAC Holdings (BACK) United States $0.001B 0.00
Psychemedics (PMD) United States $0.000B 0.00